Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Correlations of Plasma Cytokine Levels and Anti-FVIII Antibodies during Immune Tolerance Induction

Johannes Hartmann, MD, Anja Schmidt, PhD, Marko Beilfuss, Diana Stichel, Christine Heller, MD, Dirk Schwabe, MD, Thomas Klingebiel, MD, Nadia P Ewing, MD, Christoph Koenigs, MD PhD

Blood (2018) 132 (Supplement 1): 2471.

https://doi.org/10.1182/blood-2018-99-110588

Published: 2018

Journal Articles

Frequency and epitope specificity of anti–factor VIII C1 domain antibodies in acquired and congenital hemophilia A

Joerg Kahle, Aleksander Orlowski, Diana Stichel, John F. Healey, Ernest T. Parker, Marc Jacquemin, Manuela Krause, Andreas Tiede, Dirk Schwabe, Pete Lollar, Christoph Königs

Blood (2017) 130 (6): 808–816.

https://doi.org/10.1182/blood-2016-11-751347

Published: 2017

Includes: Supplemental data

Journal Articles

Elimination of FVIII-Specific B Cells By Immunotoxins Comprised of a Single FVIII Domain Fused to Pseudomonas Exotoxin a

Kerstin Brettschneider, Anja Schmidt, PhD, Joerg Kahle, PhD, Aleksander Orlowski, Diana Stichel, Karin Becker-Peters, Sonja Neimanis, PhD, Christine Heller, MD, Thomas Klingebiel, MD, Dirk Schwabe, MD, Christoph Koenigs, MD PhD

Blood (2016) 128 (22): 561.

https://doi.org/10.1182/blood.V128.22.561.561

Published: 2016

Journal Articles

Frequency and Epitope Specificity of Anti-Factor VIII C1 Domain Antibodies in Acquired and Hereditary Hemophilia Inhibitor Patient Plasma

Joerg Kahle, PhD, Aleksander Orlowski, Anja Schmidt, PhD, Kerstin Brettschneider, Thomas Klingebiel, MD, John F Healey, BS, Ernest T Parker, BA, John (Pete) S Lollar, MD, Marc Jacquemin, MD, Manuela Krause, MD, Andreas Tiede, MD PhD, Dirk Schwabe, MD, Christoph Königs, MD PhD

Blood (2015) 126 (23): 3491.

https://doi.org/10.1182/blood.V126.23.3491.3491

Published: 2015

Journal Articles

Functional Analysis of Phage Display Selected Single-Chain Variable Antibody Fragments (scFvs) Specific for Anti-FVIII Antibodies

Kerstin Brettschneider, Anja Naumann, Sonja Neimanis, PhD, Joerg Kahle, PhD, Christine Heller, MD, Thomas Klingebiel, MD, Dirk Schwabe, MD, Christoph Koenigs, PhD MD

Blood (2014) 124 (21): 1499.

https://doi.org/10.1182/blood.V124.21.1499.1499

Published: 2014

Journal Articles

Anti-FVIII Autoantibodies Share Similar Characteristics In Acquired Hemophilia A Patients With and Without An Associated Disease

Joerg Kahle, PhD, Christoph Königs, MD, PhD, Anja Naumann, Thomas Klingebiel, MD, John F Healey, Ernest T Parker, B.A., Pete Lollar, MD, Dirk Schwabe, MD, Manuela Krause, MD

Blood (2013) 122 (21): 1110.

https://doi.org/10.1182/blood.V122.21.1110.1110

Published: 2013

Journal Articles

Development of a Factor VIII-Specific Immunotherapy for Hemophilia A

Anja Naumann, Jörg Kahle, Nadia Reiss, Dirk Schwabe, Christine Heller, Thomas Klingebiel, MD, Christoph Königs, MD, PhD

Blood (2012) 120 (21): 3361.

https://doi.org/10.1182/blood.V120.21.3361.3361

Published: 2012

Journal Articles

Complete Responses in Patients with Autoimmune Lymphoproliferative Syndrome (ALPS) Using the mTOR Inhibitor Sirolimus (rapamycin)

Davi d T. Teachey, MD, Robert J Greiner, MD, Dirk Schwabe, MD, Jack Bleesing, MD, PhD, Catherine Scott Manno, MD, Kathleen Sullivan, MD, PhD, Daniel S. Wechsler, MD, PhD, Stephan A. Grupp, MD, PhD

Blood (2008) 112 (11): 2569.

https://doi.org/10.1182/blood.V112.11.2569.2569

Published: 2008

Journal Articles

Preemptive Immunotherapy with Highly Purified CD56+/CD3− Natural Killer Cells after Haploidentical Stem Cell Transplantation. A Prospective Phase II Study in 2 Centers.

Jakob R. Passweg, MD, MS, Ulrike Koehl, PhD, Martin Stern, MD, Torsten Tonn, MD, Sandrine Meyer-Monard, MD, Peter Bader, MD, Johannes Rischewski, MD, Jan Soerensen, MD, Michael Paulussen, MD, Alois Gratwohl, MD, Thomas Klingebiel, MD, Andre Tichelli, MD, Dirk Schwabe, MD

Blood (2006) 108 (11): 411.

https://doi.org/10.1182/blood.V108.11.411.411

Published: 2006

Journal Articles

Common Polymorphisms of the Interleukin-6 and Chitotriosidase Genes Are Associated with the Risk for Infection with Gram-Negative Bacteria in Children Undergoing Therapy for Acute Myeloid Leukemia.

Thomas Lehrnbecher, MD, Toralf Bernig, MD, Mitra Hanisch, Ulrike Koehl, PhD, Dirk Reinhardt, MD, Ursula Creutzig, MD, Stephen J. Chanock, MD, Thomas Klingebiel, MD, Dirk Schwabe, MD

Blood (2004) 104 (11): 1061.

https://doi.org/10.1182/blood.V104.11.1061.1061

Published: 2004

Journal Articles

Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration

Ulrike Nowak-Göttl, Elvira Ahlke, Gudrun Fleischhack, Dirk Schwabe, Rosmarie Schobess, Christiane Schumann, Ralf Junker

Blood (2003) 101 (7): 2529–2533.

https://doi.org/10.1182/blood-2002-06-1901

Published: 2003

Journal Articles

Elevated lipoprotein(a) concentration is an independent risk factor of venous thromboembolism

Ulrike Nowak-Göttl, Rosemarie Schobess, Karin Kurnik, Dirk Schwabe, Gudrun Fleischhack, Ralf Junker

Blood (2002) 99 (9): 3476–3478.

https://doi.org/10.1182/blood-2002-01-0100

Published: 2002

Journal Articles

Prospective Evaluation of the Thrombotic Risk in Children With Acute Lymphoblastic Leukemia Carrying the MTHFR TT 677 Genotype, the Prothrombin G20210A Variant, and Further Prothrombotic Risk Factors

Ulrike Nowak-Göttl, Cornelia Wermes, Ralf Junker, Hans-Georg Koch, Rosmarie Schobess, Gudrun Fleischhack, Dirk Schwabe, Silke Ehrenforth

Blood (1999) 93 (5): 1595–1599.

https://doi.org/10.1182/blood.V93.5.1595

Published: 1999

Journal Articles

TEL-AML1 Fusion Transcript in Relapsed Childhood Acute Lymphoblastic Leukemia

Karlheinz Seeger, Hans-Peter Adams, Dirk Buchwald, Birgit Beyermann, Bernhard Kremens, Charlotte Niemeyer, Jörg Ritter, Dirk Schwabe, Dörte Harms, Martin Schrappe, Günter Henze

Blood (1998) 91 (5): 1716–1722.

https://doi.org/10.1182/blood.V91.5.1716

Published: 1998

NARROW

Correlations of Plasma Cytokine Levels and Anti-FVIII Antibodies during Immune Tolerance Induction

Frequency and epitope specificity of anti–factor VIII C1 domain antibodies in acquired and congenital hemophilia A

Elimination of FVIII-Specific B Cells By Immunotoxins Comprised of a Single FVIII Domain Fused to Pseudomonas Exotoxin a

Frequency and Epitope Specificity of Anti-Factor VIII C1 Domain Antibodies in Acquired and Hereditary Hemophilia Inhibitor Patient Plasma

Functional Analysis of Phage Display Selected Single-Chain Variable Antibody Fragments (scFvs) Specific for Anti-FVIII Antibodies

Anti-FVIII Autoantibodies Share Similar Characteristics In Acquired Hemophilia A Patients With and Without An Associated Disease

Development of a Factor VIII-Specific Immunotherapy for Hemophilia A

Complete Responses in Patients with Autoimmune Lymphoproliferative Syndrome (ALPS) Using the mTOR Inhibitor Sirolimus (rapamycin)

Preemptive Immunotherapy with Highly Purified CD56+/CD3− Natural Killer Cells after Haploidentical Stem Cell Transplantation. A Prospective Phase II Study in 2 Centers.

Common Polymorphisms of the Interleukin-6 and Chitotriosidase Genes Are Associated with the Risk for Infection with Gram-Negative Bacteria in Children Undergoing Therapy for Acute Myeloid Leukemia.

Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration

Elevated lipoprotein(a) concentration is an independent risk factor of venous thromboembolism

Prospective Evaluation of the Thrombotic Risk in Children With Acute Lymphoblastic Leukemia Carrying the MTHFR TT 677 Genotype, the Prothrombin G20210A Variant, and Further Prothrombotic Risk Factors

TEL-AML1 Fusion Transcript in Relapsed Childhood Acute Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only